T-Cell proliferative response to human papillomavirus type 16 peptides: Relationship to cervical intraepithelial neoplasia

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 2, 1996, Pages 205-210

  Nakagawa, Mayumi ^a   Stites, Daniel P ^a   Farhat, Sepideh ^a   Judd, Amrit ^c   Moscicki, Anna Barbara ^a   Canchola, Alison J ^b   Hilton, Joan F ^b   Palefsky, Joel M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE; VIRUS ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0029864337     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.2.205-210.1996     Document Type: Article

References (20)

1. Altmann, A., I. Jochmus-Kudielka, R. Frank, H. Gausepohl, U. Moebius, L. Gissmann, and S. C. Meuer. 1992. Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. Eur. J. Cancer 28:326-333.
2. Berzofsky, J. A., K. B. Cease, and J. L. Cornette. 1987. Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol. Rev. 98:9-51.
3. Brown, J. 1977. A micro-method for the study of in vitro lymphocyte transformation to specific antigens. J. Immunol. Methods 18:17-32.
4. Cason, J., P. K. Kambo, J. M. Best, and D. J. McCance. 1992. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children. Int. J. Cancer 50:349-355.
5. Caussy, D., J. J. Goedert, J. Palefsky, J. Gonzales, C. S. Rabkin, R. A. DiGioia, W. C. Sanchez, R. J. Grossman, G. Colclough, S. Wiktor, A. Kramer, R. J. Biggar, and W. A. Blatner. 1990. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int. J. Cancer 46:214-219.
6. Chain, B., I. McCafferty, G. Wallace, and P. W. Askenase. 1987. Improvement of the in vitro T cell proliferation assay by a modified method that separates the antigen recognition and IL-2-dependent steps. J. Immunol. Methods 99:221-228.
7. Chen, W.-F., A. Wilson, R. Scollay, and K. Shortman. 1982. Limit-dilution assay and clonal expansion of all T cells capable of proliferation. J. Immunol. Methods 52:307-322.
8. Comerford, S. A., D. J. McCance, G. Dougan, and J. P. Tite. 1991. Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16. J. Virol. 65:4681-4690.
9. Davies, D. H., C. M. Hill, J. B. Rothbard, and B. M. Chain. 1990. Definition of murine T helper cell determinants in the major capsid protein of human papillomavirus type 16. J. Gen. Virol. 71:2691-2698.
10. DeJong, B., G. J. P. A. Anders, I. H. Van Der Meer, and J. Zijlstra. 1976. Short-term microcultures of lymphocytes from Chinese hamster peripheral blood. J. Immunol. Methods 12:91-102.
11. Dejong, B., G. J. P. A. Anders, J. Zijlstra, and I. H. Van Der Meer. 1980. Chinese hamster lymphocyte cultures. Relationship between lymphocyte proliferation, cell concentration, culture time and culture area. J. Immunol. Methods 34:295-301.
12. Fazekas de St. Groth, S. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods 49:R11-23.
13. Gao, L., B. Chain, C. Sinclair, L. Crawford, J. Zhou, J. Morris, X. Zhu, and H. Stauss. 1994. Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector. J. Gen. Virol. 75:157-164.
14. Hamsikova, E., J. Novak, V. Hofmannova, N. Muno, F. X. Bosch, S. De Sanjose, K. Shah, Z. Roth, and V. Vonka. 1994. Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J. Infect. Dis. 170:1424-1431.
15. Heino, P., S. Goldman, U. Lagerstedt, and J. Dillner. 1993. Molecular and serological studies of human papillomavirus among patients with anal epidermoid carcinoma. Int. J. Cancer 53:377-381.
16. Jenison, S. A., X.-P. Yu, J. M. Valentine, L. A. Koutsky, A. E. Christiansen, A. M. Beckmann, and D. A. Galloway. 1990. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J. Infect. Dis. 162:60-69.
17. Jha, P. K. S., V. Beral, J. Peto, H. Silke, C. Hermon, J. Deacon, D. Mant, C. Chilvers, M. P. Vessey, M. C. Pike, M. Muller, and L. Gissmann. 1993. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 341:1116-1118.
18. Jochmus-Kudielka, I., A. Schneider, R. Braun, R. Kimmig, U. Koldovsky, K. E. Schneweis, K. Seedorf, and L. Gissmann. 1989. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J. Natl. Cancer Inst. 81:1698-1704.
19. Kadish, A. S., S. L. Romney, R. Ledwidge, R. Tindle, G. J. Fernando, S. Y. Zee, M. A. Van Ranst, and R. D. Burk. 1994. Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J. Gen. Virol. 75:2277-2284.
20. Kagan, J., and S. Z. Ben-Sasson. 1980. Antigen-induced proliferation of murine T-lymphocytes in vitro. I. Characterization of the lymphocyte culture system. J. Immunol. Methods 37:15-27.